The primary objective was to assess non-inferiority -LSB- per-protocol ( PP ) population -RSB- , and then superiority -LSB- intention-to-treat ( ITT ) population -RSB- , of LM@ versus IGL according to change in HbA@c after @ weeks ( non-inferiority margin @ % , two-sided significance level @ ) .